Remel Europe Ltd. recalls Oxoid Agglutinating Sera
- Recalling company
- Remel Europe Ltd.
- Product
- Oxoid Agglutinating Sera, Salmonella 9-0 R30957301
- Reason
- Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Mar 25, 2026
- Reported
- Apr 29, 2026
- Distribution
- Worldwide - US Nationwide distribution to the states of AL, CA, FL, IA, IL, IN, MI, MN, MO, NC, NE, OH, SD, TX, WA.
- Status
- Ongoing
- Quantity
- 117 US; 950 OUS
- Lot / codes
- UDI-DI 05056080500270 lots 6172600, 6172741, 6171393, 6150168, 6107767, 3766399, 3766400, 3780497, 3719592, 3709358, 6266130, 6253410, 6260215, 6222350, 6233859, 6233858
- Company location
- Dartford, N/A
- Recall type
- Voluntary: Firm initiated
- Recall number
- Z-1923-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number Z-1923-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.